CRINETICS PHARMACEUTICALS IN

Ticker: CRNX CUSIP: 22663K107 Class: EQTY

Cormorant Asset Management, LP's Holding History (CIK: 0001583977)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 300,000 Value ($000) $13,965 Avg Close $44.52 Range $38.81 - $50.98
Q3 2025
Shares 400,000 Value ($000) $16,660 Avg Close $31.97 Range $25.83 - $47.41
Q2 2025
Shares 400,000 Value ($000) $11,504 Avg Close $30.88 Range $24.10 - $34.68
Q1 2025
Shares 600,000 Value ($000) $20,124 Avg Close $37.35 Range $31.65 - $53.55
Q4 2024
Shares 1,000,000 Value ($000) $51,130 Avg Close $55.95 Range $49.48 - $62.53
Q3 2024
Shares 1,100,000 Value ($000) $56,210 Avg Close $51.57 Range $43.71 - $55.78
Q2 2024
Shares 1,350,000 Value ($000) $60,467 Avg Close $46.18 Range $41.01 - $53.70
Q1 2024
Shares 1,150,000 Value ($000) $53,832 Avg Close $39.13 Range $33.67 - $47.58
Q4 2023
Shares 1,150,000 Value ($000) $40,917 Avg Close $30.67 Range $25.35 - $37.88
Q3 2023
Shares 1,101,904 Value ($000) $32,771 Avg Close $20.61 Range $15.76 - $31.00